ADAM9 and neoplasm: Work by Jiang et al. and Wang et al. established that miR-126 preferentially targets disintegrin and metalloproteinase 9 (ADAM9) [74,75], a protease known to enhance tumor invasion and metastasis by disrupting the extracellular matrix and aiding tumor cell motility.